4 episodes

A Ropes & Gray (RopesTalk) podcast series, focused on developments in intellectual property law from the vantage point of Ropes & Gray’s office on Pennsylvania Avenue in Washington, D.C.

IP(DC) Ropes & Gray LLP

    • Business
    • 5.0, 2 Ratings

A Ropes & Gray (RopesTalk) podcast series, focused on developments in intellectual property law from the vantage point of Ropes & Gray’s office on Pennsylvania Avenue in Washington, D.C.

    IP(DC): 5G for the C-Suite: Patent Hold-Up or Hold-Out?

    IP(DC): 5G for the C-Suite: Patent Hold-Up or Hold-Out?

    Ropes & Gray’s podcast series, IP(DC), focuses on developments in intellectual property law from the vantage point of Ropes & Gray’s office on Pennsylvania Avenue in Washington, D.C. In this episode of IP(DC), IP litigation partners Scott McKeown and Matt Rizzolo are joined by antitrust partner Chong Park to address Standard Essential Patents (SEPs) and their potential to complicate the roll-out of 5G-enabled products and infrastructure. The discussion explores risks for SEP licensors pending the FTC v. Qualcomm decision on Fair, Reasonable, and Non-discriminatory (FRAND) SEP licensing, refusal to deal, and compliance with Standard Setting Organization (SSO) obligations. On the implementer side, the discussion walks through patent hold-up and anti-competitive patent pooling practices. Matt and Scott also briefly preview 2020 legislative efforts in the patent space.

    • 24 min
    IP(DC): Inside Patent Reform Efforts, Anticipated Federal Circuit Appeals, and Patent Cases of the Upcoming Supreme Court Term

    IP(DC): Inside Patent Reform Efforts, Anticipated Federal Circuit Appeals, and Patent Cases of the Upcoming Supreme Court Term

    Ropes & Gray’s podcast series, IP(DC), focuses on developments in intellectual property law from the vantage point of Ropes & Gray’s office on Pennsylvania Avenue in Washington, D.C. In this episode of IP(DC), appellate & Supreme Court partner Doug Hallward-Driemeier joins IP partners Scott McKeown and Matt Rizzolo to discuss the upcoming Supreme Court term as it relates to patent matters, current matters at the Federal Circuit, and ongoing legislative efforts in Congress to reform 35 U.S.C. Section 101 – patent subject matter eligibility.

    • 45 min
    IP(DC): Drug Prices, Political Pressures & Patents

    IP(DC): Drug Prices, Political Pressures & Patents

    Ropes & Gray’s podcast series, IP(DC), focuses on developments in intellectual property law from the vantage point of Ropes & Gray’s office on Pennsylvania Avenue in Washington, D.C. The Trump Administration has targeted U.S. drug prices through a number of as yet unsuccessful cost control schemes—with the promise of more to come. At the same time, Congress is looking to restore patenting options for some technical areas such as medical diagnostics, while combating patent “ever-greening” for blockbuster drugs and treatments. Given this storm of legal issues, this IP(DC) podcast tackles the Administration’s confusing efforts to reign in drug pricing to date, while touching upon competing policies at play on the patent side of the business. In this episode, health care partner Tom Bulleit joins IP partners Scott McKeown and Matt Rizzolo.

    • 18 min
    IP(DC): Patent Battles – New Patent Initiatives on the Hill & Notable CAFC/SCOTUS Decisions

    IP(DC): Patent Battles – New Patent Initiatives on the Hill & Notable CAFC/SCOTUS Decisions

    Ropes & Gray’s podcast series, IP(DC), focuses on developments in intellectual property law from the vantage point of Ropes & Gray’s office on Pennsylvania Avenue in Washington, D.C.
    June 19th marked the 5th anniversary of the Supreme Court’s impactful decision in Alice Corp. v. CLS Bank, which some argue shifted the landscape in an anti-patent direction. Currently, a bipartisan group of Congressional members are working to revise Section 101 of the Patent Act. In this episode, Washington, D.C.-based litigators Scott McKeown and Matt Rizzolo discuss the scope of the proposed legislation, its prospects for passage, and the actions that patent owners and potential defendants may want to take to minimize the uncertainty that comes with potential legislative action. Matt and Scott also discuss the recently proposed Term Act, which seeks to limit patent term for some Bio/Pharma patents as well as notable decisions of the Federal Circuit and SCOTUS.

    • 31 min

Customer Reviews

5.0 out of 5
2 Ratings

2 Ratings

Top Podcasts In Business